Effects of Comorbidity on Physical Function in AS and PsA
Physical functioning was found to be affected by factors including the presence of comorbidities, female sex, disease duration and activity in patients with psoriatic arthritis.
Physical functioning was found to be affected by factors including the presence of comorbidities, female sex, disease duration and activity in patients with psoriatic arthritis.
Real-life data support the validity of switching from reference etanercept to SB4 for most patients with psoriatic arthritis.
In patients with gout who initiate urate-lowering therapy during an acute disease flare, C-reactive protein levels >30 mg/L and absence of prophylaxis may represent prognostic factors for early gout flare recurrence.
Treatment of bio-naive patients with ankylosing spondylitis with golimumab or infliximab for 6 months was associated with reduced healthcare resource utilization and increased work activity and activity.
Researchers evaluated the factors associated with the presence of peripheral manifestations in patients with spondyloarthritis.
Neural network technology may be useful when scoring disease activity on Doppler ultrasound images in patients with rheumatoid arthritis.
Early initiation of combination therapy with golimumab plus methotrexate doubled the number of patients achieving psoriatic arthritis remission compared with methotrexate alone.
Researchers report the case of a 64-year-old woman with systemic lupus erythematosus and recurrent bilateral stress fractures of the calcaneus due to long-term methotrexate use.
Researchers evaluated the effectiveness of 2 tapering strategies in patients with RA who had achieved controlled disease activity.
In patients with diffuse cutaneous systemic sclerosis, developing progressive skin fibrosis within 1 year is associated with a decline in lung function and worse survival.